Ficha del valor · trimestre archivado
AVIR
Atea Pharmaceuticals, Inc. · Healthcare · Biotechnology
17Tenedores rastreados
+2Δ titulares
27.75MAcciones mantenidas
$80.49MValor declarado
+2Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +13.3% ·
flujo de acciones +1.2% ·
nuevas posiciones netas +11.8%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 62 | -4 | 39.30M | $182.78M | +3 | −7 |
| Q1 2026 | 68 | +5 | 39.11M | $209.92M | +8 | −3 |
| Q4 2025 | 63 | +1 | 37.55M | $134.03M | +1 | — |
| Q3 2025 | 17 | +2 | 27.75M | $80.49M | +2 | — |
| Q2 2025 | 12 | 0 | 25.41M | $91.49M | +1 | −1 |
| Q1 2025 | 9 | -1 | 6.11M | $18.26M | — | −1 |
| Q4 2024 | 10 | +1 | 6.07M | $20.35M | +2 | −1 |
| Q3 2024 | 8 | 0 | 4.57M | $15.30M | +1 | −1 |
| Q2 2024 | 8 | — | 4.70M | $15.57M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 8.46M | -2.4% | $24.53M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 5.82M | +1.8% | $16.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 5.82M | +1.8% | $16.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 5.82M | +1.8% | $16.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasivo) | 4.71M | -3.6% | $13.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 4.71M | -3.6% | $13.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 4.71M | -3.6% | $13.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Geode Capital Management ✦ (pasivo) | 1.90M | -1.3% | $5.51M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasivo) | 1.90M | -1.3% | $5.51M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (pasivo) | 1.78M | +0.4% | $5.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 1.23M | — | $3.58M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 1.23M | -0.5% | $3.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Millennium Management ✦ | 487.22K | +179.2% | $1.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 471.29K | +28.6% | $1.37M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 450.56K | — | $1.31M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 364.77K | +86.2% | $1.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 364.77K | +86.2% | $1.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 340.14K | — | $986,406 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 340.14K | — | $986,406 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Wellington Management ✦ | 262.77K | -26.9% | $762,048 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | Wellington Management ✦ | 262.77K | -26.9% | $762,048 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 44 | Wellington Management ✦ | 262.77K | -26.9% | $762,048 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 97.53K | +22.1% | $283,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | Marshall Wace ✦ | 87.06K | +250.1% | $252,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 47 | Marshall Wace ✦ | 87.06K | +250.1% | $252,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 48 | Citadel Advisors ✦ | 41.73K | Nuevo | $121,014 | 0.0% | New | 1 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 13.41K | Nuevo | $38,889 | 0.0% | New | 1 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 13.41K | Nuevo | $38,889 | 0.0% | New | 1 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 13.41K | Nuevo | $38,889 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Citadel Advisors | $121,014 | 0.0% |
| AQR Capital Management | $38,889 | 0.0% |
| AQR Capital Management | $38,889 | 0.0% |
| AQR Capital Management | $38,889 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 126 tenedores, 59.16M acciones, $308.71M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API